Every patient should benefit from the power of science and advanced technology.
We are bridging the gap between science and clinical practice.
With our amazing customers, we use research to prove new ways for more accurate, more efficient and reliable care to help practitioners act with speed, insight and confidence – no matter the circumstances.
A global team of experts
Founded as a spin-out from Aarhus University, Denmark in 2013, by leading experts in perfusion imaging and AI, Cercare Medical’s solutions today are available all over the world.
Cercare Medical’s Journey
Though founded in 2013, the history of Cercare Medical and our technology goes further back.
-
Massachusetts General Hospital adapts Cercare Perfusion for neuroradiology research.
-
Cercare Perfusion is implemented at Aarhus University Hospital for a pilot project to support assessment of brain tumors.
-
FDA clearance achieved for Cercare Perfusion (MRI) – our AI-powered perfusion imaging solution.
-
Launch on the Sectra Amplifier Store making Cercare Medical solutions accessible as compatible with Sectra PACS.
-
CE Mark certification achieved for both Cercare Perfusion and Cercare Stroke.
-
Study on robust estimation of hemo-dynamic parameters in traditional DCE-MRI models.
-
Partnership established with Siemens Healthineers paving the way for making the Cercare Medical solutions accessible through the syngo.via OpenApps.
-
Publication on reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
-
Study on biased visualisation of hypoperfused tissue by computed tomography due to short imaging duration: improved classification by image down-sampling and vascular models.
-
Combat Stroke was renamed to Cercare Medical due to its growing solution portfolio.
-
Perfusion MRI-derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma.
-
Publication on the reliable estimation of capillary transit time distributions using DSC-MRI.
-
Company established under the previous name Combat Stroke as a spin-out from CFIN by Professor Kim Beuschau Mouridsen and Ph.D., MSc Mikkel Bo Hansen.
-
Publication on automatic selection of arterial input function using cluster analysis.
-
Publication on the Bayesian estimation of cerebral perfusion using a physiological model of the microvasculature.
-
Kim Beuschau Mouridsen joined The Center of Functionally Integrative Neuroscience (CFIN) established at Aarhus University by Professors Leif Østergaard in 2000.
-
Professor Leif Østergaard (Cercare Scientific Board Member) published the first-ever paper on SVD in imaging which laid the foundation for advanced perfusion imaging.
Our Leadership Team
The founders
Cercare Medical is founded by Professor Kim Beuschau Mouridsen and PhD, MSc Mikkel Bo Hansen.
In 2001 Kim Beuschau Mouridsen joined The Center of Functionally Integrative Neuroscience (CFIN) researching advanced perfusion imaging and artificial intelligence together with one of the inventors of advanced perfusion imaging, Professor Leif Østergaard – a current member of the Cercare Scientific Board.
Their discoveries have shown ground breaking opportunities for brain tissue oxygenation analysis, and in 2013 Kim combined his efforts with software engineer Mikkel Bo Hansen to bring the research to life through easy-to-use state-of-the art imaging solutions
– today known as Cercare Medical.
Grants
-
Eurostars CornerStone Grant
Support for the research of likely evolution of brain injury during an AIS.
-
EU SME Phase 2 Grant
€1,831,375 from the European Union’s Horizon 2020 research and innovation program to help finance innovation activities, including demonstration, testing, piloting, and scaling up. The grant includes coaching and business acceleration services.
-
EU SME Phase 1 Grant
Funding from the European Union’s Horizon 2020 research and innovation program for a feasibility study on the development and route to marketing of the Cercare Medical decision-support solutions for acute ischemic stroke.
-
EU Innovation Associate Grant
Cercare Medical received a grant from the European Union for funding the recruitment of an Innovation Associate for 12 months aimed at research in decision support systems.
-
Markedsmondningfonden
Cercare Medical received DKK 2,000,000 to further develop our stroke solution.
-
Technology Optimisation
$24,000,000 from the Danish Agency for Science, Technology and Innovation for the interdisciplinary MINDLab at Aarhus University secured an economic basis for validating the technology in a large patient cohort with over 220 individuals.
-
Prototype Algorithm Developed
In 2008 the first prototype algorithm identifying hypoperfused tissue in MRI perfusion images was implemented with funding from a $4,500,000 grant from the 6th EU Framework Programme.
Cercare Medical Patents
Method for calculating perfusion indicies
Method for computer-assisted delineation of tissue lesion
WIPO Link:
Method for predicting tissue outcome
WIPO link: